Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Cerebrovascular Disorders

  Free Subscription


16.05.2022

3 Ann Vasc Surg
1 BMC Neurol
2 BMJ
1 Cerebrovasc Dis
1 Circ Cardiovasc Qual Outcomes
1 Eur J Vasc Endovasc Surg
1 J Neurol
1 Lancet
3 Lancet Neurol
2 Nat Rev Neurol
1 Neurologia (Engl Ed)
4 Neurology
3 PLoS One
11 Stroke


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Vasc Surg

  1. MAZZACCARO D, Dolci M, Perego F, Delbue S, et al
    Viral Agents and Systemic Levels of Inflammatory Cytokines in Vulnerable and Stable Atherosclerotic Carotid Plaques.
    Ann Vasc Surg. 2022;82:325-333.
    PubMed         Abstract available

  2. PANC C, Guler A, Gurbak I, Tasbulak O, et al
    Association Between CRP/Albumin Ratio and Long-Term Mortality in Patients With cHronIc Limb-Threatening Ischemia Undergoing EndovaScular Therapy Below The Knee: The ACHILES-BTK Registry.
    Ann Vasc Surg. 2022;82:172-180.
    PubMed         Abstract available

  3. SCHURMAN AM, Trinh SY, Firek MA, Son AK, et al
    Surgical and Endovascular Management of Extracranial Carotid Artery Aneurysms, Outcomes From the American College of Surgeons, National Surgical Quality Improvement Program.
    Ann Vasc Surg. 2022;82:47-51.
    PubMed         Abstract available


    BMC Neurol

  4. ISENBERG DL, Henry KA, Sigal A, Deaner T, et al
    Correction: Optimizing Prehospital Stroke Systems of Care-Reacting to Changing Paradigms (OPUS-REACH): a pragmatic registry of large vessel occlusion stroke patients to create evidence-based stroke systems of care and eliminate disparities in access t
    BMC Neurol. 2022;22:171.
    PubMed        


    BMJ

  5. KHAN SU, Yedlapati SH, Lone AN, Hao Q, et al
    PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis.
    BMJ. 2022;377:e069116.
    PubMed         Abstract available

  6. HAO Q, Aertgeerts B, Guyatt G, Bekkering GE, et al
    PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations.
    BMJ. 2022;377:e069066.
    PubMed         Abstract available


    Cerebrovasc Dis

  7. CHEN Q, Huang H, Chen G, Chen J, et al
    The Effect of Cerebellar Repetitive Transcranial Magnetic Stimulation on Dysphagia due to Posterior Circulation Stroke, a Randomized Controlled Trial Protocol.
    Cerebrovasc Dis. 2022 May 9:1-6. doi: 10.1159/000524241.
    PubMed         Abstract available


    Circ Cardiovasc Qual Outcomes

  8. SHAH NS, Xi K, Kapphahn KI, Srinivasan M, et al
    Cardiovascular and Cerebrovascular Disease Mortality in Asian American Subgroups.
    Circ Cardiovasc Qual Outcomes. 2022 May 10:101161CIRCOUTCOMES121008651.
    PubMed         Abstract available


    Eur J Vasc Endovasc Surg

  9. DE BORST GJ
    The long-term effect of carotid endarterectomy on the brain.
    Eur J Vasc Endovasc Surg. 2022 May 5. pii: S1078-5884(22)00288.
    PubMed        


    J Neurol

  10. RAJENDRAM P, Fox K, Sivanandan B, Selchen D, et al
    Identifying gaps in the management of atrial fibrillation with anticoagulation for stroke prevention (GIANTS): a quality improvement initiative.
    J Neurol. 2022 May 10. pii: 10.1007/s00415-022-11159.
    PubMed         Abstract available


    Lancet

  11. LEE TC, Morris AM, Schwartz IS, McDonald EG, et al
    Allocated but not treated: the silent 16.
    Lancet. 2022;399:1775.
    PubMed        


    Lancet Neurol

  12. BIVARD A, Zhao H, Churilov L, Campbell BCV, et al
    Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trial.
    Lancet Neurol. 2022 Apr 29. pii: S1474-4422(22)00171.
    PubMed         Abstract available

  13. KVISTAD CE, Naess H, Helleberg BH, Idicula T, et al
    Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial.
    Lancet Neurol. 2022 Apr 29. pii: S1474-4422(22)00124.
    PubMed         Abstract available

  14. COUTTS SB, Yu AYX
    Tenecteplase for acute stroke: the thrombolysis puzzle.
    Lancet Neurol. 2022 Apr 29. pii: S1474-4422(22)00172.
    PubMed        


    Nat Rev Neurol

  15. LEMPRIERE S
    New role for enzyme autotaxin in stroke excitotoxicity.
    Nat Rev Neurol. 2022 May 5. pii: 10.1038/s41582-022-00666.
    PubMed        

  16. DIENER HC, Easton JD, Hart RG, Kasner S, et al
    Review and update of the concept of embolic stroke of undetermined source.
    Nat Rev Neurol. 2022 May 10. pii: 10.1038/s41582-022-00663.
    PubMed         Abstract available


    Neurologia (Engl Ed)

  17. IOMINI PA, Baranchuk A
    Interatrial block and stroke: Waiting for evidence to decide anticoagulation.
    Neurologia (Engl Ed). 2022 May 5. pii: S2173-5808(22)00045.
    PubMed        


    Neurology

  18. OVEISGHARAN S, Yu L, Barnes LL, Agrawal S, et al
    Association of Statins With Cerebral Atherosclerosis and Incident Parkinsonism in Older Adults.
    Neurology. 2022 Mar 23. pii: WNL.0000000000200182.
    PubMed         Abstract available

  19. BRAEMSWIG TB, Schlemm L, Thomalla G, Endres M, et al
    Author Response: Cerebral Microbleeds and Treatment Effect of Intravenous Thrombolysis in Acute Stroke: An Analysis of the WAKE-UP Randomized Clinical Trial.
    Neurology. 2022;98:817.
    PubMed        

  20. MEINEL TR, Seiffge DJ
    Reader Response: Cerebral Microbleeds and Treatment Effect of Intravenous Thrombolysis in Acute Stroke: An Analysis of the WAKE-UP Randomized Clinical Trial.
    Neurology. 2022;98:816-817.
    PubMed        

  21. GANESH A, Galetta S
    Editors' Note: Cerebral Microbleeds and Treatment Effect of Intravenous Thrombolysis in Acute Stroke: An Analysis of the WAKE-UP Randomized Clinical Trial.
    Neurology. 2022;98:816.
    PubMed        


    PLoS One

  22. QU S, Zhou M, Jiao S, Zhang Z, et al
    Optimizing acute stroke outcome prediction models: Comparison of generalized regression neural networks and logistic regressions.
    PLoS One. 2022;17:e0267747.
    PubMed         Abstract available

  23. STEPHENSON A, Howes S, Murphy PJ, Deutsch JE, et al
    Factors influencing the delivery of telerehabilitation for stroke: A systematic review.
    PLoS One. 2022;17:e0265828.
    PubMed         Abstract available

  24. BAKO AT, Potter T, Tannous J, Pan AP, et al
    Sex differences in post-stroke cognitive decline: A population-based longitudinal study of nationally representative data.
    PLoS One. 2022;17:e0268249.
    PubMed         Abstract available


    Stroke

  25. PACIARONI M, Caso V, Agnelli G, Mosconi MG, et al
    Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND Study.
    Stroke. 2022 May 11:101161STROKEAHA121038239. doi: 10.1161/STROKEAHA.121.038239.
    PubMed         Abstract available

  26. LI W, Huang Z, Fang W, Wang X, et al
    Remnant Cholesterol Variability and Incident Ischemic Stroke in the General Population.
    Stroke. 2022 May 11:101161STROKEAHA121037756. doi: 10.1161/STROKEAHA.121.037756.
    PubMed         Abstract available

  27. PIRSON FAVA, Boodt N, Brouwer J, Bruggeman AAE, et al
    Etiology of Large Vessel Occlusion Posterior Circulation Stroke: Results of the MR CLEAN Registry.
    Stroke. 2022 May 11:101161STROKEAHA121038054. doi: 10.1161/STROKEAHA.121.038054.
    PubMed         Abstract available

  28. MEANEY JFM, O'Donnell JS, Bridgewood C, Harbison J, et al
    Perspective: The Case for Acute Large Vessel Ischemic Stroke in COVID-19 Originating Within Thrombosed Pulmonary Venules.
    Stroke. 2022 May 11:101161STROKEAHA121038056. doi: 10.1161/STROKEAHA.121.038056.
    PubMed         Abstract available

  29. MUIR KW, Saposnik G
    Current State and Future for Emerging Stroke Therapies: Reflections and Reactions.
    Stroke. 2022 May 10:101161STROKEAHA122039796. doi: 10.1161/STROKEAHA.122.039796.
    PubMed        

  30. VAN ASSCHE M, Klug J, Dirren E, Richiardi J, et al
    Preparing for a Second Attack: A Lesion Simulation Study on Network Resilience After Stroke.
    Stroke. 2022 May 9:101161STROKEAHA121037372. doi: 10.1161/STROKEAHA.121.037372.
    PubMed         Abstract available

  31. NAVE AH, Kaynak N, Mai K, Siegerink B, et al
    Combined Oral Triglyceride and Glucose Tolerance Test After Acute Ischemic Stroke to Predict Recurrent Vascular Events: The Berlin "Cream&Sugar" Study.
    Stroke. 2022 May 9:101161STROKEAHA122038732. doi: 10.1161/STROKEAHA.122.038732.
    PubMed         Abstract available

  32. LUFT AR
    Resilience to a Second Stroke: A Novel Concept in Recovery Research.
    Stroke. 2022 May 9:101161STROKEAHA122038488. doi: 10.1161/STROKEAHA.122.038488.
    PubMed        

  33. KIM H, Kim JT, Lee JS, Kim BJ, et al
    Stroke of Other Determined Etiology: Results From the Nationwide Multicenter Stroke Registry.
    Stroke. 2022 May 9:101161STROKEAHA121037582. doi: 10.1161/STROKEAHA.121.037582.
    PubMed         Abstract available

  34. STEINBERG A, Lyden PD, Davis AP
    Bias in Stroke Evaluation: Rethinking the Cookie Theft Picture.
    Stroke. 2022 May 6:101161STROKEAHA121038515. doi: 10.1161/STROKEAHA.121.038515.
    PubMed         Abstract available

  35. BETTGER JP, Cadilhac DA
    Stroke Care Costs and Cost-Effectiveness to Inform Health Policy.
    Stroke. 2022 May 6:101161STROKEAHA122037451. doi: 10.1161/STROKEAHA.122.037451.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Cerebrovascular Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: